RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA
Clinical trials for RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for lymphoma patients: targeted drug combo shows promise in late-stage trial
Disease control OngoingThis study tests whether adding a targeted drug (polatuzumab vedotin) to standard chemotherapy helps people with diffuse large B-cell lymphoma that has come back or not responded to first treatment. About 306 adults will receive either the new combo or standard chemo alone. The m…
Matched conditions: RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA
Phase: PHASE3 • Sponsor: GWT-TUD GmbH • Aim: Disease control
Last updated May 26, 2026 06:46 UTC
-
New drug duo offers hope for Hard-to-Treat lymphoma
Disease control OngoingThis study tests a combination of two drugs, copanlisib and venetoclax, in people with diffuse large B-cell lymphoma that has come back or not responded to prior treatments. The goal is to find the safest dose and see how well the drugs shrink tumors. About 48 adults will take pa…
Matched conditions: RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 26, 2026 04:38 UTC
-
New hope for hard-to-treat lymphoma: targeted drug combo enters final testing phase
Disease control OngoingThis study tests a new drug combination (loncastuximab tesirine plus rituximab) against standard chemotherapy for adults with diffuse large B-cell lymphoma that has returned or not improved after at least one prior treatment. The goal is to see if the new combo can keep cancer fr…
Matched conditions: RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA
Phase: PHASE3 • Sponsor: ADC Therapeutics S.A. • Aim: Disease control
Last updated May 19, 2026 12:00 UTC